Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-20-063482

Options or other derivatives

  • Senior Vice President, Finance acquired 63,363 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Catinazzo Thomas Senior Vice President, Finance 2020-12-11 Grant or award · Stock Option (Right to Buy) +63,363 63,363 D
Loading xslF345X03/doc4.xml…